168 related articles for article (PubMed ID: 16823507)
1. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM).
Jara Sánchez C; Ruiz A; Martín M; Antón A; Munárriz B; Plazaola A; Schneider J; Martínez del Prado P; Alba E; Fernández-Aramburo A
Breast Cancer Res Treat; 2007 Jan; 101(2):215-23. PubMed ID: 16823507
[TBL] [Abstract][Full Text] [Related]
2. Does timing of adjuvant chemotherapy for early breast cancer influence survival?
Shannon C; Ashley S; Smith IE
J Clin Oncol; 2003 Oct; 21(20):3792-7. PubMed ID: 14551298
[TBL] [Abstract][Full Text] [Related]
3. [Impact of the interval between surgery and radiotherapy in the initial phases of breast cancer in patients who did not receive systemic adjuvant therapy].
Bahena J; Labastida Almendaro S; Ayala Hernández JR; Fernández Orozco A
Ginecol Obstet Mex; 1998 Mar; 66():87-91. PubMed ID: 9608183
[TBL] [Abstract][Full Text] [Related]
4. [Postoperative hormone therapy of breast cancer (analysis of overall survival)].
Semiglazov VF; Ivanov VG; Ivanova OA; Moiseenko VM; Tsyrlina EV; Barash NI; Popova RT; Migmanova NS; Seleznev IK; Bozhok AA
Vopr Onkol; 1996; 42(6):37-42. PubMed ID: 9123900
[TBL] [Abstract][Full Text] [Related]
5. [Some prognostic factors in the combined therapy of locally advanced breast cancer].
Voznyĭ EK; Kharchenko VP; Gurov SN; Dobrovol'skaia NIu; Bol'shakova SA
Vopr Onkol; 2000; 46(6):732-6. PubMed ID: 11219949
[TBL] [Abstract][Full Text] [Related]
6. A critical appraisal of treatment for T3N0 colon cancer.
Yo IS; Opelka FG; Bolton JS; Fuhrman GM
Am Surg; 2001 Feb; 67(2):143-8. PubMed ID: 11243538
[TBL] [Abstract][Full Text] [Related]
7. [Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?].
Kroman NT; Jensen MB; Wohlfahrt J; Mouridsen H; Andersen PK; Melbye M
Ugeskr Laeger; 2000 May; 162(22):3184-8. PubMed ID: 10850209
[TBL] [Abstract][Full Text] [Related]
8. Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological study.
Briasoulis E; Agnantis NJ; Zagorianakou P; Kamina S; Gorezi M; Pavlidis N; Bai M
J Exp Clin Cancer Res; 2001 Sep; 20(3):341-4. PubMed ID: 11718212
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment for elderly breast cancer patients over the age of 70.
Yoshinaga Y; Shirakusa T; Baba M; Beppu R; Hiratsuka M; Maekawa T; Kawahara K; Yamashita Y
Int Surg; 2003; 88(3):169-74. PubMed ID: 14584774
[TBL] [Abstract][Full Text] [Related]
10. The outcome of treatment of breast cancer in a developing country--Oman.
Al-Moundhri M; Al-Bahrani B; Pervez I; Ganguly SS; Nirmala V; Al-Madhani A; Al-Mawaly K; Grant C
Breast; 2004 Apr; 13(2):139-45. PubMed ID: 15019695
[TBL] [Abstract][Full Text] [Related]
11. The disease-free interval in breast cancer trials: scientific or spurious?
Mueller CB
Surgery; 1991 Oct; 110(4):629-34; discussion 634-5. PubMed ID: 1925953
[TBL] [Abstract][Full Text] [Related]
12. Validation of the 2001 St Gallen risk categories for node-negative breast cancer using a database from the Spanish Breast Cancer Research Group (GEICAM).
Colomer R; Viñas G; Beltran M; Izquierdo A; Lluch A; Llombart-Cussac A; Alba E; Munárriz B; Martín M;
J Clin Oncol; 2004 Mar; 22(5):961-2. PubMed ID: 14990656
[No Abstract] [Full Text] [Related]
13. Breast cancer survival and the timing of tumor removal during the menstrual cycle.
Chang S; Hulka BS; Baird DD; Ingle JN; Newman B; Graham ML; Qaqish B; Donohue JH; Melton LJ
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):881-6. PubMed ID: 9367060
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of endostatin in cancer patients.
Kuroi K; Tanaka C; Toi M
Oncol Rep; 2001; 8(2):405-9. PubMed ID: 11182064
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis of patients with breast cancer related to the timing of operation during menstrual cycle: a report of 218 patients].
Zhang B; Shao Y; Wang C
Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):203-7. PubMed ID: 9387255
[TBL] [Abstract][Full Text] [Related]
16. Feasibilty of a sleep intervention during adjuvant breast cancer chemotherapy.
Berger AM; VonEssen S; Khun BR; Piper BF; Farr L; Agrawal S; Lynch JC; Higginbotham P
Oncol Nurs Forum; 2002; 29(10):1431-41. PubMed ID: 12432414
[TBL] [Abstract][Full Text] [Related]
17. Timing of surgery related to menstrual cycle and prognosis of premenopausal women with breast cancer.
Mondini G; Decian F; Sorice G; Friedman D; Spirito C; Costantini M; Sormani MP; Civalleri D
Anticancer Res; 1997; 17(1B):787-90. PubMed ID: 9066621
[TBL] [Abstract][Full Text] [Related]
18. [Clinical implication of apoptosis of breast cancer induced by preoperative chemotherapy].
Shao Z; Li J; Wu J
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):295-7. PubMed ID: 11778553
[TBL] [Abstract][Full Text] [Related]
19. A computer program to assist in making breast cancer adjuvant therapy decisions.
Ravdin PM
Semin Oncol; 1996 Feb; 23(1 Suppl 2):43-50. PubMed ID: 8614844
[TBL] [Abstract][Full Text] [Related]
20. Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy.
Mathoulin-Portier MP; Meynard P; Charton-Bain MC; Escoute M; Bardou VJ; Puig B; Viens P; Cowen D; Houvenaeghel G; Hassoun J; Jacquemier J
Anticancer Res; 1999; 19(1B):843-7. PubMed ID: 10216503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
